Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017 (2017), Article ID 6712376, 12 pages
https://doi.org/10.1155/2017/6712376
Research Article

Can Replacing CA125 with HE4 in Risk of Malignancy Indices 1–4 Improve Diagnostic Performance in the Presurgical Assessment of Adnexal Tumors?

Department of Obstetrics, Gynecology and Oncology, Second Faculty of Medicine, Medical University of Warsaw, Kondratowicza 8, 03-242 Warsaw, Poland

Correspondence should be addressed to Nabil Abdalla; moc.oohay@alladbalibanrd

Received 8 June 2017; Accepted 28 September 2017; Published 7 November 2017

Academic Editor: Maria Barbolina

Copyright © 2017 Nabil Abdalla et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. Jacobs, D. Oram, J. Fairbanks, J. Turner, C. Frost, and J. G. Grudzinskas, “A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer,” British Journal of Obstetrics and Gynaecology, vol. 97, no. 10, pp. 922–929, 1990. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Tingulstad, B. Hagen, F. E. Skjeldestad et al., “Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses,” BJOG: An International Journal of Obstetrics & Gynaecology, vol. 103, no. 8, pp. 826–831, 1996. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Tingulstad, B. Hagen, F. E. Skjeldestad, T. Halvorsen, K. Nustad, and M. Onsrud, “The risk of malignancy index to evaluate potential ovarian cancers in local hospitals,” Obstetrics & Gynecology, vol. 93, no. 3, pp. 448–452, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Yamamoto, R. Yamada, H. Oguri, N. Maeda, and T. Fukaya, “Comparison of four malignancy risk indices in the preoperative evaluation of patients with pelvic masses,” European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 144, no. 2, pp. 163–167, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. Ovarian Cancer: Recognition and Initial Management, National Institute for Health and Clinical Excellence, https://www.nice.org.uk/guidance/cg122.
  6. Royal College of Obstetricians and Gynaecologists, “Management of suspected ovarian masses in premenopausal women,” 2011, https://www.rcog.org.uk/.
  7. E. M. J. Meys, J. Kaijser, R. F. P. M. Kruitwagen et al., “Subjective assessment versus ultrasound models to diagnose ovarian cancer: A systematic review and meta-analysis,” European Journal of Cancer, vol. 58, pp. 17–29, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Kirchhoff, I. Habben, R. Iveli, and N. Krull, “A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors,” Biology of Reproduction, vol. 45, no. 2, pp. 350–357, 1991. View at Publisher · View at Google Scholar · View at Scopus
  9. I. Hellström, J. Raycraft, M. Hayden-Ledbetter et al., “The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma,” Cancer Research, vol. 63, no. 13, pp. 3695–3700, 2003. View at Google Scholar · View at Scopus
  10. R. G. Moore, A. K. Brown, M. C. Miller et al., “The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass,” Gynecologic Oncology, vol. 108, no. 2, pp. 402–408, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. J. M. Escudero, J. M. Auge, X. Filella, A. Torne, J. Pahisa, and R. Molina, “Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases,” Clinical Chemistry, vol. 57, no. 11, pp. 1534–1544, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Timmerman, L. Valentin, T. H. Bourne, W. P. Collins, H. Verrelst, and I. Vergote, “Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) group,” Ultrasound in Obstetrics & Gynecology, vol. 16, no. 5, pp. 500–505, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. AM. Šimundić, “Measures of diagnostic accuracy: basic definitions,” EJIFCC, vol. 19, no. 4, pp. 203–211, 2009. View at Google Scholar
  14. L.-M. Wang, H. Song, X. Song, and X.-B. Zhou, “An improved risk of malignancy index in diagnosis of adnexal mass,” Chinese Medical Journal, vol. 125, no. 3, pp. 533–535, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Ashrafgangooei and M. Rezaeezadeh, “Risk of malignancy index in preoperative evaluation of pelvic masses,” Asian Pacific Journal of Cancer Prevention, vol. 12, no. 7, pp. 1727–1730, 2011. View at Google Scholar · View at Scopus
  16. N. Asif, A. Sattar, M. M. Dawood, T. Rafi, M. Aamir, and M. Anwar, “Pre-operative evaluation of ovarian mass: risk of malignancy index,” Journal of the College of Physicians and Surgeons Pakistan, vol. 14, no. 3, pp. 128–131, 2004. View at Google Scholar · View at Scopus
  17. D. Timmerman, H. Verrelst, T. H. Bourne et al., “Artificial neural network models for the preoperative discrimination between malignant and benign adnexal masses,” Ultrasound in Obstetrics & Gynecology, vol. 13, no. 1, pp. 17–25, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Vaes, R. Manchanda, P. Autier et al., “Differential diagnosis of adnexal masses: Sequential use of the risk of malignancy index and HistoScanning, a novel computer-aided diagnostic tool,” Ultrasound in Obstetrics & Gynecology, vol. 39, no. 1, pp. 91–98, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Winarto, B. J. Laihad, and L. Nuranna, “Modification of cutoff values for HE4, CA125, the risk of malignancy index, and the risk of Malignancy Algorithm for ovarian cancer detection in Jakarta, Indonesia,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 5, pp. 1949–1953, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. V. Arun-Muthuvel and V. Jaya, “Pre-operative evaluation of ovarian tumors by risk of malignancy index, CA125 and ultrasound,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 6, pp. 2929–2932, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Campos, L. O. Sarian, R. M. Jales et al., “Performance of the Risk of Malignancy Index for Discriminating Malignant Tumors in Women with Adnexal Masses,” Journal of Ultrasound in Medicine, vol. 35, no. 1, pp. 143–152, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Yavuzcan, M. Caglar, E. Ozgu et al., “Should cut-off values of the risk of malignancy index be changed for evaluation of adnexal masses in Asian and Pacific populations?” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 9, pp. 5455–5459, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Ong, A. Biswas, M. Choolani, and J. J. H. Low, “Comparison of risk of malignancy indices in evaluating ovarian masses in a southeast asian population,” Singapore Medical Journal, vol. 54, no. 3, pp. 136–139, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Abdalla, J. Winiarek, M. Bachanek, K. Cendrowski, and W. Sawicki, “Clinical, ultrasound parameters and tumor marker-based mathematical models and scoring systems in pre-surgical diagnosis of adnexal tumors,” Ginekologia Polska, vol. 87, no. 12, pp. 824–829, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Timmerman, A. C. Testa, T. Bourne et al., “Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group,” Journal of Clinical Oncology, vol. 23, no. 34, pp. 8794–8801, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Van Calster, K. Van Hoorde, L. Valentin et al., “Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study,” British Medical Journal, vol. 349, Article ID g5920, 2014. View at Publisher · View at Google Scholar
  27. J. Didkowska and U. Wojciechowska, Zachorowania i zgony na nowotwory złośliwe w Polsce, URL http, 2016, http://onkologia.org.pl/k/epidemiologia/.
  28. M. C. Yenen, I. Alanbay, E. Aktürk et al., “Comparison of risk of malignancy indices; RMI 1-4 in borderline ovarian tumor,” European Journal of Gynaecological Oncology, vol. 33, no. 2, pp. 168–173, 2012. View at Google Scholar · View at Scopus
  29. C. Anton, F. M. Carvalho, E. I. Oliveira, G. A. R. Maciel, E. C. Baracat, and J. P. Carvalho, “A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses,” Clinics, vol. 67, no. 5, pp. 437–441, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. M. A. Karlsen, N. Sandhu, C. Høgdall et al., “Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass,” Gynecologic Oncology, vol. 127, no. 2, pp. 379–383, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Valentin, D. Jurkovic, B. Van Calster et al., “Adding a single CA 125 measurement to ultrasound imaging performed by an experienced examiner does not improve preoperative discrimination between benign and malignant adnexal masses,” Ultrasound in Obstetrics & Gynecology, vol. 34, no. 3, pp. 345–354, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Van Gorp, J. Veldman, B. Van Calster et al., “Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses,” European Journal of Cancer, vol. 48, no. 11, pp. 1649–1656, 2012. View at Publisher · View at Google Scholar · View at Scopus